Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
By How Much Is The Biologics Contract Development Market Expected To Expand Between 2025 And 2029?
The biologics contract development market has witnessed rapid expansion in recent years. This market is set to increase from $7.75 billion in 2024 to $8.55 billion in 2025, achieving a compound annual growth rate (CAGR) of 10.3%. Factors contributing to its historical growth include the overall growth of the biologics market, an increase in biopharmaceuticals, the complexity of biologics, patent expirations, and an emphasis on cost efficiency.
The biologics contract development market is anticipated to experience substantial growth in the upcoming years. It is projected to expand to $13.08 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 11.2%. This growth during the forecast period is attributable to elements such as digitalization and data analytics, risk management, flexibility and scalability, increasing investment in r&d, precision medicine, and personalized therapies. Furthermore, significant trends expected in this period include regenerative medicine, risk mitigation strategies, global collaborations, the use of advanced technologies, and comprehensive technological integration.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8219&type=smp
What Are The Top Growth Drivers Impacting The Biologics Contract Development Market Outlook?
The increasing prevalence of chronic diseases is projected to drive the biologics contract development market moving forward. Chronic diseases are characterized as illnesses lasting a year or longer, requiring ongoing medical attention. This rise in chronic disease cases elevates the demand for developing new drugs, including biologics, thus boosting the biologics contract development market. For example, reports released in September 2024 by the Office for Health Improvement & Disparities, a UK-based government body, revealed that in the first half of 2023, 3,940 excess deaths were linked to chronic lower respiratory diseases, marking a 30% increase compared to expected rates. For the full year, this figure increased to 5,363, reflecting an overall 22% rise. Hence, the growing occurrence of chronic diseases will propel the growth of the biologics contract development market.
What Are The Primary Types Of Segments Analyzed In The Biologics Contract Development Market?
The biologics contract developmentmarket covered in this report is segmented –
1) By Source: Microbial; Mammalian; Others Sources
2) By Indication: Oncology; Immunological Disorders; Cardiovascular Disorders; Hematological Disorders; Others Indications
3) By Product Service: Cell Line Development; Process Development; Others Product Services
Subsegments:
1) By Microbial: Bacterial Sources; Yeast Sources; Fungal Sources
2) By Mammalian: Chinese Hamster Ovary (CHO) Cells; Human Embryonic Kidney (HEK) Cells; Hybridoma Cells
3) By Other Sources: Plant-Based Systems; Insect Cell Systems; Algal Sources
Which Key Trends Are Expected To Influence The Biologics Contract Development Market In The Coming Years?
Technological advancements are becoming increasingly prominent in the biologics contract development market. Major companies within the biologics contract development market are integrating sophisticated technologies to sustain their market position. For example, in January 2022, Lonza, a Switzerland-based contract manufacturing and development solutions company, unveiled its bYlok technology platform specifically for designing and manufacturing bispecific antibodies. This innovation helps to resolve the light-heavy chain mispairing issue, providing high yields, greater than 95% accuracy, and the capacity to maintain a mAb-like format. Pharmaceutical and biotech companies can obtain access to this platform via a simple research license.
Who Are The Primary Competitors In The Global Biologics Contract Development Market?
Major companies operating in the biologics contract development market are WuXi Biologics, Abzena Ltd., Fujifilm Diosynth Biotechnologies, KBI Biopharma, AGC Biologics, Thermo Fisher Scientific Inc, LakePharma Inc., GenScript Biotech Corporation, Bionova Scientific Inc., Boehringer Ingelheim GmbH, STC Biologics, Siegfried Evionnaz SA, BioAgilytix Labs Inc., Samsung BioLogics, Forge Biologics, Lonza Group, Catalent Inc., AbbVie Inc., Cytovance Biologics, Emergent BioSolutions, Eurofins CDMO, Meridian Life Science Inc., Merck Group, Patheon N.V., ProBioGen AG, Rentschler Biopharma SE, Sartorius AG, Syngene International Limited, Vibalogics GmbH, Yposkesi
Download The Full Report For Exclusive Market Findings:
How Does The Biologics Contract Development Market Perform Across Key Geographic Regions?
North America was the largest region in the biologics contract development market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biologics contract development market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Biologics Contract Development Market Report:
https://www.thebusinessresearchcompany.com/customise?id=8219&type=smp
Browse Through More Reports Similar to the Global Biologics Contract Development Market 2025, By The Business Research Company
Chemicals Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/chemicals-global-market-report
Ethylene Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/ethylene-global-market-report
Genetically Modified Crops Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/genetically-modified-crops-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model